<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jimenez-Pastor A</submitter><funding>Conselleria de Cultura, Educación y Ciencia, Generalitat Valenciana</funding><funding>Joan Rodés</funding><pagination>1</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12770010</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(1)</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>This study investigated the influence of hepatic vessels on the quantification of magnetic resonance imaging (MRI) proton density fat fraction (PDFF) and R2* using automated whole-liver segmentation.&lt;h4>Materials and methods&lt;/h4>This prospective multicenter study included patients with chronic liver disease having paired liver biopsy and MR exams with a standardized multiecho chemical-shift gradient echo sequence. Automated whole-liver segmentation was performed, generating two masks per patient, one including and the other excluding the major hepatic vessels. PDFF and R2* were quantified and graded for both masks. Histological grading of hepatic steatosis and iron overload severity was used as a reference standard.&lt;h4>Results&lt;/h4>A total of 377 patients were evaluated, of whom 54% had hepatic steatosis and 20% had iron overload on biopsy readings. Stratified by histological grades, there were no statistically significant differences in the distribution of PDFF or R2* between the two segmentation masks. Overall, PDFF and R2* values were minimally lower when vessels were included, with a bias of -0.06% for PDFF and -0.25 s&lt;sup>-1&lt;/sup> for R2*. A lower coefficient of variation was obtained for both imaging parameters after excluding vessels. Patients were classified in the same PDFF grades despite the segmentation approach, and only 7 cases (1.9% of the study population) were reclassified for R2* grading, all being upgraded after vessel exclusion.&lt;h4>Conclusion&lt;/h4>Excluding hepatic vessels entails nonsignificant differences in PDFF and R2* quantification. Although with limited impact, vessel exclusion improves biomarker precision in research settings demanding high accuracy and increases clinicians' confidence when using automatic tools in clinical practice.&lt;h4>Relevance statement&lt;/h4>Fat and iron quantification on MRI are key imaging biomarkers for the accurate non-invasive assessment of patients with chronic liver disease. Proton density, fat fraction, and R2* quantification show minimal differences if hepatic vessels are included or excluded from the liver segmentation mask.&lt;h4>Key points&lt;/h4>The effect of hepatic vessels on proton density, fat fraction, and R2* quantification was evaluated. No significant differences were found, excluding hepatic vessels, although their inclusion showed a small negative bias. Vessel exclusion may improve clinicians' confidence and precision in high-sensitivity applications.</pubmed_abstract><journal>European radiology experimental</journal><pubmed_title>Impact of hepatic vessels on whole liver proton density fat fraction and R2* quantification.</pubmed_title><pmcid>PMC12770010</pmcid><funding_grant_id>JR22/00002</funding_grant_id><funding_grant_id>CIGE/2022/37</funding_grant_id><pubmed_authors>Perez-Girbes A</pubmed_authors><pubmed_authors>Marti-Aguado D</pubmed_authors><pubmed_authors>Alfaro-Cervello C</pubmed_authors><pubmed_authors>Pereira B</pubmed_authors><pubmed_authors>Marti-Bonmati L</pubmed_authors><pubmed_authors>Jimenez-Pastor A</pubmed_authors><pubmed_authors>Alberich-Bayarri A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Impact of hepatic vessels on whole liver proton density fat fraction and R2* quantification.</name><description>&lt;h4>Objectives&lt;/h4>This study investigated the influence of hepatic vessels on the quantification of magnetic resonance imaging (MRI) proton density fat fraction (PDFF) and R2* using automated whole-liver segmentation.&lt;h4>Materials and methods&lt;/h4>This prospective multicenter study included patients with chronic liver disease having paired liver biopsy and MR exams with a standardized multiecho chemical-shift gradient echo sequence. Automated whole-liver segmentation was performed, generating two masks per patient, one including and the other excluding the major hepatic vessels. PDFF and R2* were quantified and graded for both masks. Histological grading of hepatic steatosis and iron overload severity was used as a reference standard.&lt;h4>Results&lt;/h4>A total of 377 patients were evaluated, of whom 54% had hepatic steatosis and 20% had iron overload on biopsy readings. Stratified by histological grades, there were no statistically significant differences in the distribution of PDFF or R2* between the two segmentation masks. Overall, PDFF and R2* values were minimally lower when vessels were included, with a bias of -0.06% for PDFF and -0.25 s&lt;sup>-1&lt;/sup> for R2*. A lower coefficient of variation was obtained for both imaging parameters after excluding vessels. Patients were classified in the same PDFF grades despite the segmentation approach, and only 7 cases (1.9% of the study population) were reclassified for R2* grading, all being upgraded after vessel exclusion.&lt;h4>Conclusion&lt;/h4>Excluding hepatic vessels entails nonsignificant differences in PDFF and R2* quantification. Although with limited impact, vessel exclusion improves biomarker precision in research settings demanding high accuracy and increases clinicians' confidence when using automatic tools in clinical practice.&lt;h4>Relevance statement&lt;/h4>Fat and iron quantification on MRI are key imaging biomarkers for the accurate non-invasive assessment of patients with chronic liver disease. Proton density, fat fraction, and R2* quantification show minimal differences if hepatic vessels are included or excluded from the liver segmentation mask.&lt;h4>Key points&lt;/h4>The effect of hepatic vessels on proton density, fat fraction, and R2* quantification was evaluated. No significant differences were found, excluding hepatic vessels, although their inclusion showed a small negative bias. Vessel exclusion may improve clinicians' confidence and precision in high-sensitivity applications.</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-06-06T10:54:25.855Z</modification><creation>2026-05-29T03:12:22.232Z</creation></dates><accession>S-EPMC12770010</accession><cross_references><pubmed>41491129</pubmed><doi>10.1186/s41747-025-00663-1</doi></cross_references></HashMap>